BioInformatics Inc.

BioInformatics Inc. empowers companies in the life science space with comprehensive market research and custom services, enabling evidence-based decision-making in product roadmaps, corporate strategy, and customer loyalty initiatives. As a prominent research and advisory firm founded in 1994, the company specializes in delivering data-driven insights across lab equipment, instruments, consumables, and other key elements driving scientific discovery.

With a global network of scientists, BioInformatics aids clients in understanding market potential, product research, consumer insights, due diligence, and marketing strategies. The company's proven success is reflected in its client roster, including top-tier players such as Agilent, Beckman Coulter, and Thermo Fisher Scientific. BioInformatics also serves a diverse range of stakeholders, from pharmaceutical companies to non-profit societies, providing unparalleled market research services and insights vital for informed decision-making.

BioInformatics' recent Series B investment of $21.00M at 05 November 2018 from BroadOak Capital Partners, RCT, and Pablo Capital reinforces its position as a leading provider in the industry. With a solid foundation in place and a strong backing, the company is well-positioned to capitalize on the evolving needs of the life science sector, and continue driving impactful change within the industry.

BioInformatics Inc., together with its sister companies within the Science and Medicine Group (SDi, IMV, and Kalorama), exhibits a commitment to upholding trusted research standards and delivering value to clients in the analytical instrument, diagnostic, medical imaging, and clinical diagnostics sectors.